Development of a highly selective Plasmodium falciparum proteasome inhibitor with anti-malaria activity in humanized mice.

Lin G, Zhan W, Zhang H, Ginn J, Leung A, Liu YJ, Michino M, Toita A, Wong TT, Imaeda T, Hara R, Yukawa T, Chelebieva S, Tumwebaze PK, Lafuente-Monasterio MJ, Vendome J, Martinez-Martinez MS, Beuming T, Sato K, Aso K, Rosenthal PJ, Cooper RA, Meinke PT, Nathan CF, Kirkman LA